Japan, the leading country in technological advancement and research in Asia, is starting to observe a rapid development in its 3D printing industry as the demand for 3D printing technology is substantially increasing.
Companies and experts in the manufacturing and health care industries have particularly demonstrated strong interests in 3D printing technology, experimenting with various 3D printers, 3D printing techniques and alternative layered manufacturing mechanisms.
In July, the International Data Corporation (IDC) Japan announced that the total sales of the domestic 3D printing market in 2015 reached ¥34.4 billion or $310 million, which showed a 104.4% annual growth compared to the previous year.
The report from the IDC also explicitly analyzed different areas of the Japanese 3D printing industry and suggested their projected growth by 2020. The following areas include:
- Services market: projected to grow to ¥20.2 billion by 2020
- Material market presumed to be worth ¥29.97 billion by 2020
- Professional 3D printers market to be worth ¥23.2 billion by 2020
The healthcare and automotive industries have been heavily involved in both the material and professional 3D printer markets, with surgeons and healthcare experts focusing on experimenting with various 3D printing materials for implants and automotive manufacturers utilizing 3D printers to produce parts with cost and time efficiency.
In early 2015, the New Energy and Industrial Technology Development Organization (NEDO), a Kanagawa-based semi-public body, announced a ¥2.5 billion fund to spur the growth of highly advanced 3D printing mechanisms for human tissue regeneration.Takeshi Sakamoto, director of the biotechnology and medical technology department at NEDO, has been using 3D printing technology and testing various materials to 3D print human cells with precision and accuracy, which can be leveraged to treat previously incurable diseases.
With the Japanese government estimating that the regenerative medicine industry is presumed to grow to ¥1 trillion by 2030, Sakamoto and NEDO believe that emerging and innovative technologies like 3D printing will lead the market.
“Using Japan’s advanced technology to create 3-D tissues with cells, we aim to (put) innovative products for regenerative medicine . . . into practical use ahead of other countries. This will strengthen our international competitiveness,” said NEDO.
Tsuyoshi Takato, a professor of tissue engineering at the University of Tokyo’s School of Medicine, also noted that 3D printing technology will remain a vital element for the growth of the regenerative medicine industry, as 3D printers are capable of creating complex human tissue with reduced costs and time. Takato and his team have developed a bioprinter and are working to create custom 3D printed bone and tissue for implantation in humans.
Earlier this year, 3DPrint.com also reported that the Japanese heavy industrial technology manufacturer Matsuura Machinery joined the UK-based Manufacturing Technology Centre (MTC), adding its large-scale industrial Lumex Avance-25 3D printing and CNC hybrid systems to the development and demonstration center. Japanese 3D printing companies have started to distribute and introduce their 3D printers internationally, with hopes of finding regions with high demand for professional 3D printers.
As large yet unconventional industries in Japan begin to target 3D printing technology, the demand for 3D printers will surge over the next few years. Specifically, professional and large-scale 3D printers will continue to be distributed across the nation and the 3D printer market will grow rapidly. Discuss in the Japanese 3D Printing forum at 3DPB.com.[Sources: IDC, Japan Times]
You May Also Like
RSNA Releases Guidelines for Medical 3D Printing
Part of the thrill of 3D printing is in that sense of lawlessness: experiencing the ability to create and manufacture on a whim. In the medical field, however, rules and...
FELIXprinters Providing Bespoke 3D Printing Solutions for Specific Customer Applications
Last month, family-owned industrial 3D printer manufacturer FELIXprinters officially launched its next generation Pro L and Pro XL 3D printers from its corporate headquarters and factory in the Netherlands – solidifying...
Bioprinting 101 – Part 17, Stem Cells
Mesenchymal Stem Cell Stem cells have been an interesting topic within the medical field for ages. There lies a certain polarizing feel when one talks about the use of stem...
Dr. Anthony Atala Explains the Frontiers of Bioprinting for Regenerative Medicine at Wake Forest
Anthony Atala is a pediatric surgeon, urologist and directs the Wake Forest Institute for Regenerative Medicine (WFIRM) in North Carolina. Together with 400 colleagues and in a work that spans...